Shane Dormady, MD, discusses the unique emotional care needs of young adults with cancer, emphasizing hope and holistic support for better outcomes. Cancer care for younger adults emphasizes emotional ...
Subcutaneous daratumumab with lenalidomide significantly increased MRD-negative conversion rates compared to lenalidomide ...
Post-CAR T infection prophylaxis should follow European Hematology Association/European Society for Blood and Marrow ...
In this episode of the Treating Together podcast, Edward S. Kim, MD, MBA, and Neel Shah, MD, discuss the rapid advancements in lung cancer therapy, the challenges community physicians face in staying ...
David Chism, MD: For pairing it with the immunotherapy, I would prefer just 1 chemotherapy rather than ...
Cancer care for younger adults emphasizes emotional well-being and multidisciplinary support, transforming treatment ...
The FDA approved Guardant 360 CDx for identifying ESR1 mutations in advanced breast cancer patients eligible for imlunestrant ...
In an interview with Targeted Oncology, Shane Dormady, MD, medical director of El Camino Health Cancer Center, highlights the unique challenges and differences in the priorities o ...
Explore the latest advancements in muscle-invasive bladder cancer treatment, including immunotherapy and novel therapies ...
An expert discusses the MARIPOSA study’s impact on managing central nervous system (CNS) involvement in EGFR-mutated non–small cell lung cancer, emphasizing improved brain progression-free survival, ...
The IMFORTE trial represents a breakthrough for patients with ES-SCLC who complete initial treatment without disease progression, offering new hope through maintenance therapy wit ...
An expert discusses how the IMpower133 trial established atezolizumab plus chemotherapy as standard care for extensive-stage small cell lung cancer, improving overall survival from 10.3 to 12.3 months ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback